Literature DB >> 27563114

Influenza vaccination: in the UK and across Europe.

Simon de Lusignan, Ana Correa, Joanna Ellis, Richard Pebody.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27563114      PMCID： PMC5198692          DOI： 10.3399/bjgp16X686677

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  8 in total

1.  Vaccines against influenza WHO position paper – November 2012.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-11-23

2.  Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season.

Authors:  R G Pebody; H K Green; N Andrews; H Zhao; N Boddington; Z Bawa; H Durnall; N Singh; A Sunderland; L Letley; J Ellis; A J Elliot; M Donati; G E Smith; S de Lusignan; M Zambon
Journal:  Euro Surveill       Date:  2014-06-05

3.  Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2014-03-07

4.  Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.

Authors:  Marc Baguelin; Stefan Flasche; Anton Camacho; Nikolaos Demiris; Elizabeth Miller; W John Edmunds
Journal:  PLoS Med       Date:  2013-10-08       Impact factor: 11.069

5.  Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England.

Authors:  Rhian McNaughton; Elizabeth Lynn; Vicki Osborne; Abigail Coughtrie; Deborah Layton; Saad Shakir
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

6.  Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15.

Authors:  Richard G Pebody; Helen K Green; Nick Andrews; Nicola L Boddington; Hongxin Zhao; Ivelina Yonova; Joanna Ellis; Sophia Steinberger; Matthew Donati; Alex J Elliot; Helen E Hughes; Sameera Pathirannehelage; David Mullett; Gillian E Smith; Simon de Lusignan; Maria Zambon
Journal:  Euro Surveill       Date:  2015

7.  Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice.

Authors:  Laura J Dexter; M Dawn Teare; Matthew Dexter; A Niroshan Siriwardena; Robert C Read
Journal:  BMJ Open       Date:  2012-05-11       Impact factor: 2.692

8.  Who uses pharmacy for flu vaccinations? Population profiling through a UK pharmacy chain.

Authors:  Claire Anderson; Tracey Thornley
Journal:  Int J Clin Pharm       Date:  2016-01-28
  8 in total
  10 in total

1.  Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence.

Authors:  Ilaria Loperto; Andrea Simonetti; Antonio Nardone; Maria Triassi
Journal:  Hum Vaccin Immunother       Date:  2019-03-25       Impact factor: 3.452

2.  RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions.

Authors:  Simon de Lusignan; Ana Correa; Gillian E Smith; Ivelina Yonova; Richard Pebody; Filipa Ferreira; Alex J Elliot; Douglas Fleming
Journal:  Br J Gen Pract       Date:  2017-10       Impact factor: 5.386

3.  Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population.

Authors:  Stefano Capri; Marco Barbieri; Chiara de Waure; Sara Boccalini; Donatella Panatto
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

4.  Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses.

Authors:  Alexander Domnich; Ilaria Manini; Giovanna Elisa Calabrò; Chiara de Waure; Emanuele Montomoli
Journal:  Vaccines (Basel)       Date:  2019-12-13

5.  Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey.

Authors:  Alexander Domnich; Maura Cambiaggi; Alessandro Vasco; Luca Maraniello; Filippo Ansaldi; Vincenzo Baldo; Paolo Bonanni; Giovanna Elisa Calabrò; Claudio Costantino; Chiara de Waure; Giovanni Gabutti; Vincenzo Restivo; Caterina Rizzo; Francesco Vitale; Riccardo Grassi
Journal:  Vaccines (Basel)       Date:  2020-11-30

6.  Association between Influenza Vaccine Administration and Primary Care Consultations for Respiratory Infections: Sentinel Network Study of Five Seasons (2014/2015-2018/2019) in the UK.

Authors:  Vaishnavi Parimalanathan; Mark Joy; Pieter Jan Van Dam; Xuejuan Fan; Simon de Lusignan
Journal:  Int J Environ Res Public Health       Date:  2021-01-10       Impact factor: 3.390

7.  An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderly.

Authors:  Elettra Fallani; Andrea Orsi; Alessio Signori; Giancarlo Icardi; Alexander Domnich
Journal:  Hum Vaccin Immunother       Date:  2021-12-29       Impact factor: 3.452

8.  Incidence of Lower Respiratory Tract Infections and Atopic Conditions in Boys and Young Male Adults: Royal College of General Practitioners Research and Surveillance Centre Annual Report 2015-2016.

Authors:  Simon de Lusignan; Ana Correa; Richard Pebody; Ivelina Yonova; Gillian Smith; Rachel Byford; Sameera Rankiri Pathirannehelage; Christopher McGee; Alex J Elliot; Mariya Hriskova; Filipa Im Ferreira; Imran Rafi; Simon Jones
Journal:  JMIR Public Health Surveill       Date:  2018-04-30

9.  Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.

Authors:  Simon de Lusignan; Gaël Dos Santos; Rachel Byford; Anne Schuind; Silvia Damaso; Vishvesh Shende; Chris McGee; Ivelina Yonova; Filipa Ferreira
Journal:  Adv Ther       Date:  2018-07-11       Impact factor: 3.845

10.  Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season.

Authors:  Simon de Lusignan; Silvia Damaso; Filipa Ferreira; Rachel Byford; Christopher McGee; Sameera Pathirannehelage; Vishvesh Shende; Ivelina Yonova; Alexander Schmidt; Anne Schuind; Gael Dos Santos
Journal:  Hum Vaccin Immunother       Date:  2020-03-02       Impact factor: 3.452
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.